Illumina Inc. (ILMN)

242.63
11.44 4.95
NASDAQ : Health Technology
Prev Close 231.19
Open 232.00
Day Low/High 231.52 / 244.20
52 Wk Low/High 167.98 / 256.64
Volume 2.52M
Avg Volume 810.70K
Exchange NASDAQ
Shares Outstanding 146.75M
Market Cap 35.00B
EPS 5.00
P/E Ratio 48.48
Div & Yield N.A. (N.A)

Latest News

Square Is One of 4 Upset Picks in Our Latest 'Sweet 16' Stock Selections

Square Is One of 4 Upset Picks in Our Latest 'Sweet 16' Stock Selections

Watch for these upstart names to topple some big-caps going forward.

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference, and invites investors to participate via webcast.

Illumina Reports Financial Results For Fourth Quarter And Fiscal Year 2017

Illumina Reports Financial Results For Fourth Quarter And Fiscal Year 2017

Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the fourth quarter and fiscal year 2017.

Illumina Awarded $26.7M In Patent Suit Against Ariosa Diagnostics, Inc.

Illumina Awarded $26.7M In Patent Suit Against Ariosa Diagnostics, Inc.

Illumina, Inc. (NASDAQ: ILMN) announced today that a federal jury in San Francisco has ruled in its favor in a patent infringement suit filed against Ariosa Diagnostics, Inc.

Jim's Daily Rundown

In today's video, Jim discusses the government shutdown, an Eli Lilly downgrade, Schlumberger after Friday's earnings, and several other market-related topics.

Jim Cramer: The 3 Best Sectors That Lifted the Stock Market

Jim Cramer: The 3 Best Sectors That Lifted the Stock Market

It's hard to understand the magnitude of the change.

Jim's Daily Rundown

Jim discusses yesterday's market reversal and what to look for, GE news, Apple, healthcare and the financials.

Illumina To Announce Fourth Quarter And Fiscal Year 2017 Financial Results On Tuesday, January 30, 2018

Illumina To Announce Fourth Quarter And Fiscal Year 2017 Financial Results On Tuesday, January 30, 2018

Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for fourth quarter and fiscal year 2017 following the close of market on Tuesday, January 30, 2018.

Luna DNA Announces Dawn Barry, Former Illumina VP, As President

Luna DNA Announces Dawn Barry, Former Illumina VP, As President

Barry joins existing leadership team, which includes several Illumina veterans, to drive discovery of genomic data, enabled by the blockchain

Jim's Daily Rundown

In today's video, Jim discusses our newest initiation in Constellation Brands, Danaher at the JP Morgan Healthcare conference, and energy stocks.

Cramer: Lessons From the Market and ICR

Cramer: Lessons From the Market and ICR

You can make a case to buy any of the stocks of the companies at ICR.

Thermo Fisher Scientific And Illumina Sign Agreement To Provide Research Market Broader Access To Ion AmpliSeq Technology

Thermo Fisher Scientific And Illumina Sign Agreement To Provide Research Market Broader Access To Ion AmpliSeq Technology

Thermo Fisher Scientific and Illumina, Inc. (NASDAQ: ILMN) today announced they have signed a commercial agreement that enables Illumina to sell Ion AmpliSeq technology to researchers who conduct scientific studies on...

The ISeq™ 100 Delivers The Data Quality And Accuracy That Illumina Is Known For, At A Price Point Of Less Than $20,000.(Photo: Business Wire)

The ISeq™ 100 Delivers The Data Quality And Accuracy That Illumina Is Known For, At A Price Point Of Less Than $20,000.(Photo: Business Wire)

Illumina, Inc. (NASDAQ: ILMN) announced today the launch of the iSeq™ 100 Sequencing System.

Illumina And KingMed Diagnostics Partner To Develop Next-Generation Sequencing Technology For Chinese FDA Approval

Illumina And KingMed Diagnostics Partner To Develop Next-Generation Sequencing Technology For Chinese FDA Approval

Illumina, Inc. (NASDAQ: ILMN) and KingMed Diagnostics (SSE: 603882.

Illumina To Webcast Upcoming Investor Conference Presentations

Illumina To Webcast Upcoming Investor Conference Presentations

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be presenting at the following investor conference and invited investors to participate via webcast.

First Genomic Platform Powered By The Blockchain Raises $2 Million In Funding; Backed By Illumina Veterans

First Genomic Platform Powered By The Blockchain Raises $2 Million In Funding; Backed By Illumina Veterans

Community-owned database empowers individuals with cryptocurrency for contributing genomic data

Aimee Hoyt (Photo: Business Wire)

Aimee Hoyt (Photo: Business Wire)

Illumina, Inc. (NASDAQ:ILMN) today announced Aimee Hoyt, an accomplished and strategic talent leader, will head its human resources team.

Six Off the Beaten Path Healthcare Stock Gems

Six Off the Beaten Path Healthcare Stock Gems

These lesser-known diagnostic and life sciences firms are involved in areas from genetic tools to telemedicine.

Illumina Opens First Commercial And Customer Training Center In France

Illumina Opens First Commercial And Customer Training Center In France

Illumina, Inc. (NASDAQ:ILMN) today announced the opening of its Solutions Center on the Genopole Campus in Évry, near Paris.

16 Amazing Stocks to Trade in This Unstoppable Bull Market

16 Amazing Stocks to Trade in This Unstoppable Bull Market

After a shortened trading week light on volume, the S&P 500 is losing some steam. But Fundstrat says index uptrends 'remain intact' moving toward the New Year.

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference, and invites investors to participate via webcast.

Illumina Wins Infringement Suit Against Premaitha Health Plc And Ariosa Diagnostics, Inc.

Illumina Wins Infringement Suit Against Premaitha Health Plc And Ariosa Diagnostics, Inc.

Illumina, Inc. (NASDAQ: ILMN) announced today that the High Court of Justice, Chancery Division, Patents Court in the United Kingdom issued a judgment in its favor in the patent infringement suit filed against Premaitha...

Illumina Takes Over #128 Spot From Cimarex Energy

Illumina Takes Over #128 Spot From Cimarex Energy

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Illumina Inc has taken over the #128 spot from Cimarex Energy Co , according to ETF Channel. Below is a chart of Illumina Inc versus Cimarex Energy Co plotting their respective rank within the S&P 500 over time (ILMN plotted in blue; XEC plotted in green): In forming the rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components were ranked according to those averages.

Illumina NextSeq 550Dx (Photo: Business Wire)

Illumina NextSeq 550Dx (Photo: Business Wire)

Illumina, Inc. (NASDAQ: ILMN) announced today the introduction of its NextSeq™ 550Dx instrument, the company's second FDA-regulated and CE-IVD marked next-generation sequencing (NGS) system.

Illumina Stock Sees Short Interest Drop 11%

Illumina Stock Sees Short Interest Drop 11%

The most recent short interest data has been released for the 10/31/2017 settlement date, which shows a 314,698 share decrease in total short interest for Illumina Inc , to 2,537,042, a decrease of 11.04% since 10/13/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

TheStreet Quant Rating: B (Buy)